Document is current
Any future updates will be listed below
-
Authors
Mergental, Hynek https://orcid.org/0000-0001-5480-9380
Laing, Richard W.
Kirkham, Amanda J.
Perera, M. Thamara P. R.
Boteon, Yuri L. https://orcid.org/0000-0002-1709-9284
Attard, Joseph
Barton, Darren https://orcid.org/0000-0003-0106-5861
Curbishley, Stuart
Wilkhu, Manpreet
Neil, Desley A. H. https://orcid.org/0000-0001-9800-6811
Hübscher, Stefan G.
Muiesan, Paolo
Isaac, John R.
Roberts, Keith J.
Abradelo, Manuel
Schlegel, Andrea
Ferguson, James
Cilliers, Hentie
Bion, Julian
Adams, David H.
Morris, Chris https://orcid.org/0000-0001-9102-6668
Friend, Peter J.
Yap, Christina https://orcid.org/0000-0002-6715-2514
Afford, Simon C.
Mirza, Darius F. https://orcid.org/0000-0002-7531-9089
-
Funding
Funding for this research was provided by:
Wellcome Trust
- License Information
-
More Information
Article History
Received: 30 July 2019
Accepted: 17 April 2020
First Online: 16 June 2020
Competing interests
: P.J.F. is a co-founder, chief medical officer and consultant to OrganOx Ltd and also holds shares in the company, he was involved in the study design and funding application, but was not involved in the conduct of the clinical trial. C.M. is an OrganOx Ltd employee and provided the device technical support. H.M. received consultancy fees for lecturing and training activities for OrganOx Ltd. All other co-authors declare no competing interests. This paper presents independent research supported by the NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
